US6114133A
(en)
*
|
1994-11-14 |
2000-09-05 |
Elan Pharmaceuticals, Inc. |
Methods for aiding in the diagnosis of Alzheimer's disease by measuring amyloid-β peptide (x-≧41)
|
US7427392B1
(en)
|
1994-11-14 |
2008-09-23 |
Elan Pharmaceuticals, Inc. |
Methods for aiding in the diagnosis of alzheimer's disease by measuring amyloid-β peptide (x-≧41) and tau
|
US20030068316A1
(en)
*
|
1997-02-05 |
2003-04-10 |
Klein William L. |
Anti-ADDL antibodies and uses thereof
|
US20060178302A1
(en)
*
|
1997-02-05 |
2006-08-10 |
Northwestern University & The University Of Southern California |
Amyloid beta protein (globular assembly and uses thereof)
|
ATE402717T1
(de)
|
1997-04-09 |
2008-08-15 |
Intellect Neurosciences Inc |
Für die termini des beta-amyloids spezifische, rekombinante antikörper, dafür kodierende dna und verfahren zu ihrer verwendung
|
US8173127B2
(en)
*
|
1997-04-09 |
2012-05-08 |
Intellect Neurosciences, Inc. |
Specific antibodies to amyloid beta peptide, pharmaceutical compositions and methods of use thereof
|
ES2136535B1
(es)
*
|
1997-04-15 |
2000-08-16 |
Consejo Superior Investigacion |
Peptido sintetico para la produccion de anticuerpos contra el peptido beta amiloide 1-42.
|
US7005295B1
(en)
|
1997-04-16 |
2006-02-28 |
Wyeth |
β-amyloid peptide-binding proteins and polynucleotides encoding the same
|
WO1998046636A2
(en)
*
|
1997-04-16 |
1998-10-22 |
American Home Products Corporation |
β-AMYLOID PEPTIDE-BINDING PROTEINS AND POLYNUCLEOTIDES ENCODING THE SAME
|
US6787319B2
(en)
|
1997-04-16 |
2004-09-07 |
American Home Products Corp. |
β-amyloid peptide-binding proteins and polynucleotides encoding the same
|
US6905686B1
(en)
|
1997-12-02 |
2005-06-14 |
Neuralab Limited |
Active immunization for treatment of alzheimer's disease
|
US6761888B1
(en)
*
|
2000-05-26 |
2004-07-13 |
Neuralab Limited |
Passive immunization treatment of Alzheimer's disease
|
US6710226B1
(en)
|
1997-12-02 |
2004-03-23 |
Neuralab Limited |
Transgenic mouse assay to determine the effect of Aβ antibodies and Aβ Fragments on alzheimer's disease characteristics
|
US7179892B2
(en)
*
|
2000-12-06 |
2007-02-20 |
Neuralab Limited |
Humanized antibodies that recognize beta amyloid peptide
|
US6750324B1
(en)
|
1997-12-02 |
2004-06-15 |
Neuralab Limited |
Humanized and chimeric N-terminal amyloid beta-antibodies
|
US7588766B1
(en)
|
2000-05-26 |
2009-09-15 |
Elan Pharma International Limited |
Treatment of amyloidogenic disease
|
US6787523B1
(en)
|
1997-12-02 |
2004-09-07 |
Neuralab Limited |
Prevention and treatment of amyloidogenic disease
|
TWI239847B
(en)
*
|
1997-12-02 |
2005-09-21 |
Elan Pharm Inc |
N-terminal fragment of Abeta peptide and an adjuvant for preventing and treating amyloidogenic disease
|
US7790856B2
(en)
|
1998-04-07 |
2010-09-07 |
Janssen Alzheimer Immunotherapy |
Humanized antibodies that recognize beta amyloid peptide
|
US20080050367A1
(en)
|
1998-04-07 |
2008-02-28 |
Guriq Basi |
Humanized antibodies that recognize beta amyloid peptide
|
US6923964B1
(en)
|
1997-12-02 |
2005-08-02 |
Neuralab Limited |
Active immunization of AScr for prion disorders
|
US7964192B1
(en)
|
1997-12-02 |
2011-06-21 |
Janssen Alzheimer Immunotherapy |
Prevention and treatment of amyloidgenic disease
|
US6913745B1
(en)
|
1997-12-02 |
2005-07-05 |
Neuralab Limited |
Passive immunization of Alzheimer's disease
|
AU2003262458B2
(en)
*
|
1998-05-21 |
2008-06-19 |
University Of Tennessee Research Foundation |
Methods for amyloid removal using anti-amyloid antibodies
|
US20030147882A1
(en)
*
|
1998-05-21 |
2003-08-07 |
Alan Solomon |
Methods for amyloid removal using anti-amyloid antibodies
|
MXPA00011348A
(es)
|
1998-05-21 |
2003-04-22 |
Univ Tennesse Res Corp |
Metodos para la remocion de material amiloide utilizando anticuerpos anti-amiloide.
|
US6787637B1
(en)
|
1999-05-28 |
2004-09-07 |
Neuralab Limited |
N-Terminal amyloid-β antibodies
|
UA81216C2
(en)
*
|
1999-06-01 |
2007-12-25 |
|
Prevention and treatment of amyloid disease
|
ES2312348T3
(es)
*
|
1999-06-16 |
2009-03-01 |
Boston Biomedical Research Institute |
Control inmunologico de niveles de beta-amiloide in vivo.
|
TR200202799T3
(tr)
|
2000-02-24 |
2003-03-21 |
Washington University St.Louis |
AB peptidini sekanslayan insanlaştırılmış antikorlar
|
WO2001077167A2
(en)
*
|
2000-04-05 |
2001-10-18 |
University Of Tennessee Research Corporation |
Methods of investigating, diagnosing, and treating amyloidosis
|
JP2003516929A
(ja)
*
|
2000-06-01 |
2003-05-20 |
ニユーララブ・リミテツド |
アミロイド形成性疾患の予防および治療
|
CA2414772C
(en)
*
|
2000-07-07 |
2011-06-28 |
Jan Naslund |
Prevention and treatment of alzheimer's disease
|
US7700751B2
(en)
|
2000-12-06 |
2010-04-20 |
Janssen Alzheimer Immunotherapy |
Humanized antibodies that recognize β-amyloid peptide
|
PE20020574A1
(es)
*
|
2000-12-06 |
2002-07-02 |
Wyeth Corp |
Anticuerpos humanizados que reconocen el peptido amiloideo beta
|
US6815175B2
(en)
*
|
2001-03-16 |
2004-11-09 |
Cornell Research Foundation, Inc. |
Anti-amyloid peptide antibody based diagnosis and treatment of a neurological disease or disorder
|
DE60229051D1
(de)
|
2001-04-30 |
2008-11-06 |
Lilly Co Eli |
Humanisierte antikörper
|
ES2437875T3
(es)
|
2001-04-30 |
2014-01-14 |
Eli Lilly And Company |
Anticuerpos humanizados que reconocen el péptido beta-amiloide
|
DK1944040T3
(da)
|
2001-08-17 |
2012-10-29 |
Univ Washington |
Analysefremgangsmåde for Alzheimers sygdom
|
JP2005519284A
(ja)
*
|
2002-03-01 |
2005-06-30 |
アプレラ コーポレイション |
アミノ酸鎖に対する、化学修飾のセットの適合性の決定
|
MY139983A
(en)
*
|
2002-03-12 |
2009-11-30 |
Janssen Alzheimer Immunotherap |
Humanized antibodies that recognize beta amyloid peptide
|
US20040107871A1
(en)
*
|
2002-08-09 |
2004-06-10 |
Defeo Maureen A. |
Aluminum trihydrate containing slurries
|
CA2501945A1
(en)
*
|
2002-10-09 |
2004-04-22 |
Rinat Neuroscience Corp. |
Methods of treating alzheimer's disease using antibodies directed against amyloid beta peptide and compositions thereof
|
DE10303974A1
(de)
|
2003-01-31 |
2004-08-05 |
Abbott Gmbh & Co. Kg |
Amyloid-β(1-42)-Oligomere, Verfahren zu deren Herstellung und deren Verwendung
|
KR20050118669A
(ko)
*
|
2003-02-01 |
2005-12-19 |
뉴랄랩 리미티드 |
가용성 a-베타에 대한 항체를 생성하기 위한 능동 면역화
|
ATE468886T1
(de)
|
2003-02-10 |
2010-06-15 |
Applied Molecular Evolution |
Abeta-bindende moleküle
|
US8663650B2
(en)
|
2003-02-21 |
2014-03-04 |
Ac Immune Sa |
Methods and compositions comprising supramolecular constructs
|
US7732162B2
(en)
|
2003-05-05 |
2010-06-08 |
Probiodrug Ag |
Inhibitors of glutaminyl cyclase for treating neurodegenerative diseases
|
TWI374893B
(en)
|
2003-05-30 |
2012-10-21 |
Janssen Alzheimer Immunotherap |
Humanized antibodies that recognize beta amyloid peptide
|
US7807171B2
(en)
|
2003-07-25 |
2010-10-05 |
Ac Immune Sa |
Therapeutic vaccine targeted against P-glycoprotein 170 for inhibiting multidrug resistance in the treatment of cancers
|
SE0401601D0
(sv)
|
2004-06-21 |
2004-06-21 |
Bioarctic Neuroscience Ab |
Protofibril specific antibodies and uses thereof
|
EA016357B1
(ru)
*
|
2004-07-30 |
2012-04-30 |
Ринат Ньюросайенс Корп. |
Антитела, направленные против бета-амилоидного пептида, и способы их применения
|
US20080199879A1
(en)
*
|
2004-10-28 |
2008-08-21 |
Sanko Junyaku Co., Ltd. |
Method of Assaying Alzheimer's Disease and Diagnostic Reagent
|
JP2008519988A
(ja)
*
|
2004-11-12 |
2008-06-12 |
ファイザー・インク |
アミロイド−ベータペプチドを測定する方法
|
TW200636066A
(en)
|
2004-12-15 |
2006-10-16 |
Elan Pharm Inc |
Humanized antibodies that recognize beta amyloid peptide
|
TW200635607A
(en)
|
2004-12-15 |
2006-10-16 |
Elan Pharm Inc |
Humanized Aβ antibodies for use in improving cognition
|
WO2006081171A1
(en)
|
2005-01-24 |
2006-08-03 |
Amgen Inc. |
Humanized anti-amyloid antibody
|
RU2007124933A
(ru)
*
|
2005-01-28 |
2009-03-10 |
Вайет (Us) |
Стабилизированные жидкие полипептидные составы
|
GT200600031A
(es)
|
2005-01-28 |
2006-08-29 |
|
Formulacion anticuerpo anti a beta
|
MY148086A
(en)
*
|
2005-04-29 |
2013-02-28 |
Rinat Neuroscience Corp |
Antibodies directed against amyloid-beta peptide and methods using same
|
EA015148B1
(ru)
|
2005-06-17 |
2011-06-30 |
Элан Фарма Интернэшнл Лимитед |
СПОСОБЫ ОЧИСТКИ Aβ-СВЯЗЫВАЮЩЕГО БЕЛКА, СОДЕРЖАЩЕГО ОБЛАСТЬ FC
|
RU2008120027A
(ru)
*
|
2005-10-21 |
2009-11-27 |
Мерк энд Ко., Инк. (US) |
Анти-addl моноклональное антитело и его применение
|
AU2006319358B2
(en)
|
2005-11-30 |
2012-01-19 |
AbbVie Deutschland GmbH & Co. KG |
Anti-Abeta globulomer antibodies, antigen-binding moieties thereof, corresponding hybridomas, nucleic acids, vectors, host cells, methods of producing said antibodies, compositions comprising said antibodies, uses of said antibodies and methods of using said antibodies
|
KR101439828B1
(ko)
|
2005-11-30 |
2014-09-17 |
애브비 인코포레이티드 |
아밀로이드 베타 단백질에 대한 모노클로날 항체 및 이의 용도
|
RU2015111675A
(ru)
*
|
2005-12-12 |
2015-08-10 |
Ац Иммуне Са |
Специфические в отношении амилоида бета (а бета) 1-42 моноклональные антитела, обладающие терапевтическими свойствами
|
RU2429244C2
(ru)
*
|
2006-03-23 |
2011-09-20 |
Байоарктик Ньюросайенс Аб |
Улучшенные селективные в отношении протофибрилл антитела и их применение
|
US8784810B2
(en)
|
2006-04-18 |
2014-07-22 |
Janssen Alzheimer Immunotherapy |
Treatment of amyloidogenic diseases
|
KR101605207B1
(ko)
*
|
2006-07-14 |
2016-03-22 |
에이씨 이뮨 에스.에이. |
아밀로이드 베타에 대해 인간화된 항체
|
FR2903999B1
(fr)
*
|
2006-07-19 |
2008-09-05 |
Galderma Res & Dev S N C Snc |
Modulateurs de sc4mol dans le traitement de l'acne ou de l'hyperseborrhee
|
US20100104577A1
(en)
*
|
2006-10-10 |
2010-04-29 |
Golde Todd E |
Methods and materials related to anti-a (beta) antibodies
|
US8455626B2
(en)
|
2006-11-30 |
2013-06-04 |
Abbott Laboratories |
Aβ conformer selective anti-aβ globulomer monoclonal antibodies
|
PT2842967T
(pt)
|
2007-01-18 |
2017-01-13 |
Lilly Co Eli |
Fab beta amilóide peguilado
|
WO2008104386A2
(en)
|
2007-02-27 |
2008-09-04 |
Abbott Gmbh & Co. Kg |
Method for the treatment of amyloidoses
|
EP2481408A3
(en)
|
2007-03-01 |
2013-01-09 |
Probiodrug AG |
New use of glutaminyl cyclase inhibitors
|
US8003097B2
(en)
|
2007-04-18 |
2011-08-23 |
Janssen Alzheimer Immunotherapy |
Treatment of cerebral amyloid angiopathy
|
DK2142514T3
(da)
|
2007-04-18 |
2015-03-23 |
Probiodrug Ag |
Thioureaderivater som glutaminylcyclase-inhibitorer
|
US8048420B2
(en)
|
2007-06-12 |
2011-11-01 |
Ac Immune S.A. |
Monoclonal antibody
|
US8613923B2
(en)
*
|
2007-06-12 |
2013-12-24 |
Ac Immune S.A. |
Monoclonal antibody
|
EP2009445A1
(en)
*
|
2007-06-29 |
2008-12-31 |
Institut Pasteur |
Use of a camelid single-domain antibody for detecting an oligomeric form of an amyloid beta peptide and its applications
|
DK2182983T3
(da)
|
2007-07-27 |
2014-07-14 |
Janssen Alzheimer Immunotherap |
Behandling af amyloidogene sygdomme med humaniserede anti-abeta antistoffer
|
EP2238166B1
(en)
*
|
2007-10-05 |
2013-11-27 |
Genentech, Inc. |
Use of anti-amyloid beta antibody in ocular diseases
|
RU2542967C2
(ru)
*
|
2007-10-05 |
2015-02-27 |
Дженентек, Инк. |
Применение антитела против амилоида бета при глазных заболеваниях
|
JO3076B1
(ar)
|
2007-10-17 |
2017-03-15 |
Janssen Alzheimer Immunotherap |
نظم العلاج المناعي المعتمد على حالة apoe
|
US9067981B1
(en)
|
2008-10-30 |
2015-06-30 |
Janssen Sciences Ireland Uc |
Hybrid amyloid-beta antibodies
|
AU2010294214B2
(en)
|
2009-09-11 |
2015-05-07 |
Vivoryon Therapeutics N.V. |
Heterocylcic derivatives as inhibitors of glutaminyl cyclase
|
JP6026284B2
(ja)
|
2010-03-03 |
2016-11-16 |
プロビオドルグ エージー |
グルタミニルシクラーゼの阻害剤
|
AU2011226074B2
(en)
|
2010-03-10 |
2015-01-22 |
Vivoryon Therapeutics N.V. |
Heterocyclic inhibitors of glutaminyl cyclase (QC, EC 2.3.2.5)
|
CA2796339C
(en)
|
2010-04-15 |
2020-03-31 |
Abbott Laboratories |
Amyloid-beta binding proteins
|
EP2560953B1
(en)
|
2010-04-21 |
2016-01-06 |
Probiodrug AG |
Inhibitors of glutaminyl cyclase
|
SG187173A1
(en)
|
2010-07-30 |
2013-02-28 |
Ac Immune Sa |
Safe and functional humanized anti beta-amyloid antibody
|
WO2012020124A1
(en)
|
2010-08-12 |
2012-02-16 |
Ac Immune S.A. |
Vaccine engineering
|
EP3533803B1
(en)
|
2010-08-14 |
2021-10-27 |
AbbVie Inc. |
Anti-amyloid-beta antibodies
|
TW201223561A
(en)
|
2010-10-26 |
2012-06-16 |
Ac Immune Sa |
Preparation of an antigenic construct
|
JP6050264B2
(ja)
|
2011-03-16 |
2016-12-21 |
プロビオドルグ エージー |
グルタミニルシクラーゼの阻害剤としてのベンゾイミダゾール誘導体
|
US20140302532A1
(en)
|
2011-04-12 |
2014-10-09 |
Quanterix Corporation |
Methods of determining a treatment protocol for and/or a prognosis of a patient's recovery from a brain injury
|
JP2012102131A
(ja)
*
|
2012-01-05 |
2012-05-31 |
Elan Pharma Internatl Ltd |
アミロイド形成性疾患の予防および治療
|
CN103665113A
(zh)
*
|
2012-09-14 |
2014-03-26 |
深圳市安群生物工程有限公司 |
人Aβ42抗原决定簇多肽、抗原、抗体、用途及试剂盒
|
KR102308915B1
(ko)
|
2012-10-15 |
2021-10-06 |
메디뮨 리미티드 |
아밀로이드 베타에 대한 항체
|
JP2016103980A
(ja)
*
|
2013-03-08 |
2016-06-09 |
パナソニックヘルスケア株式会社 |
ハイブリドーマ及びモノクローナル抗体
|
KR20230129449A
(ko)
|
2014-07-10 |
2023-09-08 |
바이오악틱 에이비 |
개선된 Aβ 프로토피브릴 결합 항체
|
PL3461819T3
(pl)
|
2017-09-29 |
2020-11-30 |
Probiodrug Ag |
Inhibitory cyklazy glutaminylowej
|